PHARMIS BIOFARMACEUTICA

🇵🇹Portugal35 contracts awarded

Get the tenders PHARMIS BIOFARMACEUTICA goes after

New tenders in the sectors and countries where PHARMIS BIOFARMACEUTICA wins contracts — by e-mail, every day. Free.

Track Record

PHARMIS BIOFARMACEUTICA has a proven track record with 36 awarded contracts across Portugal and Spain. The majority of their contracts are concentrated in Portugal, which accounts for 97% of their portfolio, with additional presence in 1 other market.

The company's expertise spans general supplies, health and medical services, governance and public administration, industry and manufacturing and transport and logistics, among other sectors. Their portfolio includes supply contracts (36).

Their areas of specialization include pharmaceuticals, general supplies, artificial intelligence and hospitals, reflecting a diverse technical capability across multiple disciplines.

The company has secured contracts through various procurement platforms and funding agencies, including Portugal BASE Portal and Spain PLACSP.

Notable Contracts

Medicines

This tender concerns the procurement of medicines. The scope of supply includes a range of pharmaceutical products required by the contracting authority, likely a healthcare institution, hospital,…

— Unidade Local de Saúde do Alto Alentejo, Epe

Portugalsupply contractsbase_gov_pt
Invitation to submit a proposal by direct award for the acquisition of O4 - Octreotide [0.1 Mg/1Ml; F/Amp]

This tender is an invitation for proposals via a direct award process for the acquisition of a specific pharmaceutical product: Octreotide, with a dosage of 0.1 mg/1ml, supplied in an ampoule…

— Unidade Local de Saúde de Lisboa Ocidental, e. P. E.

Portugalsupply contractsbase_gov_pt
Invitation to submit proposals under framework agreement(s) 2023/0304 - Group 4 medicines: blood; 2023/0481 - Miscellaneous medicines; 2023/0491 - Oncological and immunomodulatory medicines; 2023/0495 - Genitourinary medicines; 2024/0900 - Antiretroviral medicines for the treatment of Hiv infection; 2024/0961 - Miscellaneous medicines; 2025/1303 - Medicines

This invitation requests proposals from potential suppliers under a series of established framework agreements for the procurement of various categories of medicines. The framework agreements,…

— Unidade Local de Saúde de São João E.P.E.

Portugalsupply contractsbase_gov_pt

Key contracting authorities

  • Instituto Português de Oncologia do Porto Francisco Gentil, Epe· 5
  • Unidade Local de Saúde do Alto Alentejo E.P.E· 3
  • Unidade Local de Saúde do Alto Alentejo, Epe· 2
  • Unidade Local de Saúde de Lisboa Ocidental, e. P. E.
  • Unidade Local de Saúde de São João E.P.E.

Frequently asked questions about PHARMIS BIOFARMACEUTICA

Who is PHARMIS BIOFARMACEUTICA?

PHARMIS BIOFARMACEUTICA is a public-sector contractor based in Portugal with 36 awarded contracts tracked on BidsFactory across 2 countries.

How many public contracts has PHARMIS BIOFARMACEUTICA won?

PHARMIS BIOFARMACEUTICA has won 36 public procurement contracts on BidsFactory.

What sectors does PHARMIS BIOFARMACEUTICA work in?

PHARMIS BIOFARMACEUTICA is most active in general supplies, health and medical services and governance and public administration.

Which contracting authorities have awarded contracts to PHARMIS BIOFARMACEUTICA?

PHARMIS BIOFARMACEUTICA's most frequent contracting authorities include Instituto Português de Oncologia do Porto Francisco Gentil, Epe, Unidade Local de Saúde do Alto Alentejo E.P.E and Unidade Local de Saúde do Alto Alentejo, Epe.

Where does BidsFactory get PHARMIS BIOFARMACEUTICA's contract history?

Data is aggregated from Portugal BASE Portal and Spain PLACSP and refreshed every 6 hours.

Data sources: Portugal BASE Portal (35), Spain PLACSP. Refreshed every 6 hours from official procurement portals.

Funding Sources

Countries of Operation

Company Overview

35
Contracts
1
Countries
1
Sources

Contact Information

Portugal

Looking for tenders?

Find open procurement opportunities from international development organizations.